FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
ROMA Calculation Tool Using Elecsys Assays
K Number: K153607
·
Decision Jun 15, 2016
Classifications
1
FEI Numbers
5
Registration Numbers
5
Same Product Code
5
Applicant Total
183
Review Days
181
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- ROMA Calculation Tool Using Elecsys Assays
- K Number
- K153607
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 866.6050
- Medical Specialty
- Obstetrics/Gynecology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Roche Diagnostics
- Date Received
- December 17, 2015
- Decision Date
- June 15, 2016
- Product Code
- ONX
- Advisory Committee
- Obstetrics/Gynecology
- Review Advisory Committee
- IM
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| ONX | Ovarian Adnexal Mass Assessment Score Test System | FDA class 2 | Obstetrics/Gynecology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (ONX), ordered by most recent decision date.
Lumipulse G ROMA
FDA 510(k)
FDA Class 2
·Obstetrics/Gynecology
ARCHITECT ROMA
FDA 510(k)
FDA Class 2
·Obstetrics/Gynecology
OVA1 Next Generation
FDA 510(k)
FDA Class 2
·Obstetrics/Gynecology
ROMA (HE4 EIA + ARCHITECT CA 125 II)
FDA 510(k)
FDA Class 2
·Obstetrics/Gynecology
OVA1 TEST
FDA 510(k)
FDA Class 2
·Obstetrics/Gynecology
Other Clearances by Roche Diagnostics
| K Number | Device Name | ||
|---|---|---|---|
| K252323 | cobas pulse blood glucose monitoring system | Jun 12, 2026 | Substantially Equivalent |
| K252280 | Elecsys Anti-SARS-CoV-2 S | Apr 13, 2026 | Substantially Equivalent |
| K260048 | Elecsys Anti-HAV IgM | Apr 7, 2026 | Substantially Equivalent |
| K260049 | Elecsys Anti-HBc IgM | Apr 7, 2026 | Substantially Equivalent |
| K260046 | Elecsys Anti-HBc II | Apr 7, 2026 | Substantially Equivalent |
| K260026 | Tina-quant Cardiac high sensitivity CRP III | Apr 2, 2026 | Substantially Equivalent |
| K253490 | Glucose HK Gen.3; ONLINE DAT Methadone II; cobas pro integrated solutions | Feb 12, 2026 | Substantially Equivalent |
| K253491 | ISE indirect K for Gen.2; ISE indirect Na for Gen.2; ISE indirect Cl for Gen.2; cobas pro integrated solutions | Feb 12, 2026 | Substantially Equivalent |
| K253839 | Elecsys Anti-SARS-CoV-2 | Dec 17, 2025 | Substantially Equivalent |
| K253188 | CoaguChek XS Plus System | Oct 24, 2025 | Substantially Equivalent |